Analytical Data
-
Gene name
PE2R4
- Application
-
Alternative Names
PTGER2
-
Species
Human
-
Source
Baculovirus
-
Tag
Tag Free
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P35408
-
Expression Region
P4-F217, F260-C346, N7Q, N177Q
-
Protein Length
Partial
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PE2R4 recombinant protein is derived from the PE family of proteins, which are associated with the pathogenicity of certain bacteria, particularly those from the Mycobacterium genus. The research into PE2R4 focuses on its structural and functional properties, as it is believed to play a critical role in the interaction between mycobacteria and host immune systems. Understanding the mechanisms of PE2R4 can provide insights into the bacterial survival strategies within host cells and may shed light on the development of new therapeutic approaches for diseases such as tuberculosis. The protein is characterized by a unique structure that influences its interactions with host biomolecules, making it a target for drug discovery and vaccine development. The study of PE2R4 has important implications for understanding bacterial virulence, immune evasion, and the development of novel interventions to combat mycobacterial infections. Researchers employ various techniques such as X-ray crystallography, NMR spectroscopy, and functional assays to elucidate the role of PE2R4 in the pathogenesis of mycobacterial diseases. Overall, the investigation of this recombinant protein contributes to the broader understanding of host-pathogen interactions and the ongoing efforts to address global health challenges associated with mycobacterial infections.
